A spontaneous intramural hematoma of the bowel presenting as obstruction in a child receiving low-molecular-weight heparin. J Pediatr Hematol Oncol 2005 Oct;27(10):558-60
Date
10/12/2005Pubmed ID
16217261DOI
10.1097/01.mph.0000183865.56533.9bScopus ID
2-s2.0-27544469399 (requires institutional sign-in at Scopus site) 23 CitationsAbstract
Low-molecular-weight heparin (LMWH) is a safe and effective alternative to unfractionated heparin and coumadin in the treatment and prophylaxis of thrombosis in children. When compared with these more established anticoagulants, it is easier to achieve therapeutic levels and the incidence of hemorrhagic complications is equivalent or lower. In children there is less published experience than in adults, but the low frequency of significant bleeding appears to be similar. The authors describe a child on therapeutic doses of LMWH for a deep vein thrombosis who spontaneously developed an intramural hemorrhage in his small bowel, leading to infarction and a partial bowel resection.
Author List
Shaw PH, Ranganathan S, Gaines BAuthor
Peter H. Shaw MD Associate Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnticoagulantsGastrointestinal Hemorrhage
Hematoma
Heparin, Low-Molecular-Weight
Humans
Infant
Intestinal Diseases
Intestinal Obstruction
Intestine, Small
Male
